CXL OPHTHALMICS, INC.

Profile

Company Names

CXL OPHTHALMICS, INC.

Addresses

161 FOREST STREET, SHERBORN, MA 01770

Phone Numbers

339-234-6020

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2022

State Incorporated:

DELAWARE

Total Amount Raised:

$26,392,935.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-09-28 
$26,392,935.00 
$50,298,762.00 
$23,905,827.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CURT 
 
LABELLE 
DIRECTOR
SAFEOP SURGICAL, INC.   |  EXAGEN DIAGNOSTICS INC   |  KUROBE PHARMACEUTICALS, INC.   |  EYENOVIA, INC.   |  INPRESS TECHNOLOGIES, INC.   |  REVELATION BIOSCIENCES, INC   |  OPHIREX, INC.   |  CXL OPHTHALMICS, INC.   |  VEDANTA BIOSCIENCES, INC.   |  RESOLUTE RESOURCES LTD./CAN   |  NOVOCUFF, INC.
SUSAN 
 
MACDONALD 
DIRECTOR
CXL OPHTHALMICS, INC.
MARC 
 
ODRICH 
DIRECTOR
TEARSOLUTIONS, INC.   |  CXL OPHTHALMICS, INC.
EDWARD 
 
PARSONS 
EXECUTIVE OFFICER
CXL OPHTHALMICS, INC.
JONATHAN 
 
TALAMO 
DIRECTOR
CXL OPHTHALMICS, INC.   |  OCUDYNE, INC.
MICHAEL 
 
WEBB 
EXECUTIVE OFFICER, DIRECTOR
ASCENT THERAPEUTICS INC   |  VIRTIFY, INC.   |  ANCHORTHERAPEUTICS, INC   |  FITWALL VENTURES LLC   |  COC HOLDCO, INC.   |  XCOVERY HOLDING CO LLC   |  FITWALL VENTURES, LLC   |  VAPOTHERM INC   |  TYROGENEX, INC.   |  FLICKRAY, INC.   |  CXL OPHTHALMICS, INC.   |  FENIX24, INC.   |  PARSCAPE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-10-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
PIPER SANDLER + CO.
665